| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.08 |